Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Natural Killer T-Cells | 3 | 2017 | 326 | 1.030 |
Why?
|
Rheumatic Diseases | 2 | 2021 | 538 | 1.010 |
Why?
|
B-Lymphocytes | 7 | 2020 | 4928 | 0.910 |
Why?
|
Antibodies, Antinuclear | 2 | 2020 | 345 | 0.810 |
Why?
|
Interleukin-10 | 2 | 2016 | 1211 | 0.760 |
Why?
|
Lupus Erythematosus, Systemic | 5 | 2020 | 2122 | 0.660 |
Why?
|
Antigens, Ly | 1 | 2017 | 304 | 0.580 |
Why?
|
Lymphocyte Activation | 5 | 2020 | 5892 | 0.520 |
Why?
|
Autoimmunity | 3 | 2020 | 1335 | 0.480 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2018 | 1020 | 0.470 |
Why?
|
Autoantibodies | 2 | 2016 | 2008 | 0.330 |
Why?
|
Mice, Inbred NZB | 3 | 2016 | 64 | 0.320 |
Why?
|
Autoimmune Diseases | 1 | 2018 | 2113 | 0.310 |
Why?
|
Dendritic Cells | 1 | 2017 | 2731 | 0.280 |
Why?
|
Spondylitis, Ankylosing | 2 | 2016 | 145 | 0.270 |
Why?
|
Th17 Cells | 3 | 2021 | 753 | 0.250 |
Why?
|
Genetic Predisposition to Disease | 3 | 2022 | 17432 | 0.240 |
Why?
|
Immunologic Memory | 2 | 2021 | 1385 | 0.210 |
Why?
|
Single-Cell Analysis | 3 | 2021 | 2161 | 0.200 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2020 | 65 | 0.200 |
Why?
|
TYK2 Kinase | 1 | 2020 | 42 | 0.200 |
Why?
|
Clonal Anergy | 1 | 2020 | 175 | 0.190 |
Why?
|
Spondylarthritis | 1 | 2020 | 53 | 0.190 |
Why?
|
Mycobacterium tuberculosis | 2 | 2021 | 1852 | 0.180 |
Why?
|
Antigens, CD1d | 2 | 2017 | 233 | 0.170 |
Why?
|
Immune Tolerance | 2 | 2018 | 2332 | 0.170 |
Why?
|
Genetic Loci | 3 | 2021 | 2614 | 0.150 |
Why?
|
Chlamydia muridarum | 1 | 2015 | 9 | 0.150 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2018 | 211 | 0.140 |
Why?
|
Interleukin-7 | 1 | 2016 | 150 | 0.140 |
Why?
|
Chromosomes, Mammalian | 1 | 2016 | 153 | 0.140 |
Why?
|
Ribonucleoproteins | 1 | 2018 | 385 | 0.140 |
Why?
|
Plasma Cells | 1 | 2018 | 610 | 0.140 |
Why?
|
Genetic Variation | 2 | 2021 | 6664 | 0.130 |
Why?
|
Antigens | 1 | 2020 | 1514 | 0.130 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2021 | 819 | 0.130 |
Why?
|
Quantitative Trait Loci | 1 | 2022 | 1979 | 0.130 |
Why?
|
Chromosomes | 1 | 2017 | 616 | 0.130 |
Why?
|
Peru | 3 | 2022 | 847 | 0.130 |
Why?
|
HLA Antigens | 1 | 2020 | 1552 | 0.120 |
Why?
|
Interleukin-17 | 2 | 2016 | 891 | 0.120 |
Why?
|
Macrophages, Alveolar | 1 | 2015 | 441 | 0.120 |
Why?
|
Alleles | 2 | 2021 | 7101 | 0.110 |
Why?
|
Chlamydia Infections | 1 | 2015 | 351 | 0.110 |
Why?
|
Macrophage Activation | 1 | 2015 | 592 | 0.110 |
Why?
|
Interferon-gamma | 3 | 2016 | 3277 | 0.110 |
Why?
|
Genetic Engineering | 1 | 2018 | 957 | 0.110 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1909 | 0.100 |
Why?
|
Animals | 11 | 2021 | 170894 | 0.100 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2020 | 4383 | 0.090 |
Why?
|
Mice | 9 | 2020 | 81128 | 0.090 |
Why?
|
Epistasis, Genetic | 1 | 2011 | 371 | 0.090 |
Why?
|
Promoter Regions, Genetic | 1 | 2020 | 6051 | 0.080 |
Why?
|
Gene Expression Regulation | 4 | 2022 | 12435 | 0.080 |
Why?
|
Lupus Nephritis | 1 | 2011 | 328 | 0.080 |
Why?
|
RNA, Small Interfering | 1 | 2017 | 3615 | 0.080 |
Why?
|
Tuberculosis | 1 | 2019 | 1829 | 0.080 |
Why?
|
Disease Progression | 2 | 2021 | 13308 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 2 | 2018 | 3684 | 0.070 |
Why?
|
Mice, Congenic | 2 | 2017 | 104 | 0.070 |
Why?
|
Cytokines | 2 | 2017 | 7223 | 0.070 |
Why?
|
Apoptosis | 2 | 2018 | 10119 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5495 | 0.060 |
Why?
|
Macrophages | 1 | 2018 | 5814 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2020 | 15600 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2017 | 11762 | 0.060 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 22929 | 0.050 |
Why?
|
Mice, Knockout | 1 | 2016 | 15258 | 0.050 |
Why?
|
Humans | 14 | 2022 | 717280 | 0.050 |
Why?
|
Flow Cytometry | 3 | 2016 | 6134 | 0.050 |
Why?
|
Signal Transduction | 2 | 2020 | 23997 | 0.050 |
Why?
|
Gene Knock-In Techniques | 1 | 2020 | 449 | 0.040 |
Why?
|
DNA, Single-Stranded | 1 | 2020 | 346 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2019 | 780 | 0.040 |
Why?
|
Palatine Tonsil | 1 | 2018 | 195 | 0.040 |
Why?
|
Biotechnology | 1 | 2019 | 279 | 0.040 |
Why?
|
Muramidase | 1 | 2017 | 175 | 0.040 |
Why?
|
Toll-Like Receptor 9 | 1 | 2018 | 208 | 0.040 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2019 | 495 | 0.040 |
Why?
|
Receptors, Interleukin-7 | 1 | 2016 | 43 | 0.040 |
Why?
|
New Zealand | 1 | 2017 | 384 | 0.040 |
Why?
|
Lung | 1 | 2015 | 9781 | 0.040 |
Why?
|
Reverse Transcription | 1 | 2016 | 45 | 0.040 |
Why?
|
Cohort Studies | 1 | 2018 | 39891 | 0.040 |
Why?
|
Adult | 6 | 2021 | 212470 | 0.040 |
Why?
|
Interleukins | 1 | 2020 | 803 | 0.030 |
Why?
|
Chickens | 1 | 2017 | 881 | 0.030 |
Why?
|
Interleukin-23 | 1 | 2016 | 183 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2018 | 817 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2019 | 1904 | 0.030 |
Why?
|
Synovial Fluid | 1 | 2016 | 365 | 0.030 |
Why?
|
Sex Factors | 2 | 2021 | 10661 | 0.030 |
Why?
|
Gene Expression | 2 | 2019 | 8013 | 0.030 |
Why?
|
Risk Factors | 1 | 2021 | 70863 | 0.030 |
Why?
|
Cell Line | 2 | 2020 | 16693 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2017 | 920 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1692 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1787 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2016 | 781 | 0.030 |
Why?
|
Aged | 3 | 2021 | 162862 | 0.030 |
Why?
|
Male | 6 | 2021 | 351399 | 0.030 |
Why?
|
Receptors, Complement 3d | 1 | 2011 | 135 | 0.030 |
Why?
|
Spleen | 1 | 2017 | 2473 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2021 | 21811 | 0.030 |
Why?
|
Th1 Cells | 1 | 2016 | 1082 | 0.020 |
Why?
|
Middle Aged | 3 | 2021 | 215054 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4329 | 0.020 |
Why?
|
Female | 5 | 2021 | 377934 | 0.020 |
Why?
|
Monocytes | 1 | 2019 | 2657 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2017 | 2816 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3968 | 0.020 |
Why?
|
Base Sequence | 1 | 2019 | 13317 | 0.020 |
Why?
|
Up-Regulation | 1 | 2017 | 4356 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2017 | 2961 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7733 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2669 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2015 | 2184 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 3057 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6294 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2015 | 6676 | 0.020 |
Why?
|
Genotype | 1 | 2019 | 12923 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2017 | 9927 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2016 | 4480 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10802 | 0.020 |
Why?
|
Age Factors | 1 | 2021 | 18798 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2016 | 5160 | 0.010 |
Why?
|
Young Adult | 2 | 2021 | 56249 | 0.010 |
Why?
|
Cell Movement | 1 | 2015 | 5465 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 85143 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 11951 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4352 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39302 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2011 | 4486 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 13716 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 58528 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2011 | 20097 | 0.010 |
Why?
|
Child | 1 | 2021 | 74388 | 0.010 |
Why?
|
Mutation | 1 | 2018 | 29491 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2011 | 10376 | 0.010 |
Why?
|
Concepts
(139)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_